Annual Meeting 2014: DETERMINATION trial: A phase III multi-center study examining the timing of SCT for MM

Annual Meeting 2014: DETERMINATION trial: A phase III multi-center study examining the timing of SCT for MM

318 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA


DETERMINATION trial: A phase III multi-center study examining the timing of stem cell transplant for MM

The DETERMINATION study will have 1300 patients (700 in France and over 600 in the US) to determine when transplant is best used in newly diagnosed myeloma patients now that newer therapies are available. The study will also look at how the Revlimid/Velcade/Dex combo works as initial treatment and how lenalidomide affects progression as maintenance therapy.

Visit our website at: http://www.myeloma.org
Up Next Autoplay